ReviewFrontiers in nutrition2026
Biochemical and molecular mechanisms of probiotic action: current concepts and emerging therapeutic applications.
Review in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Probiotic effects are mediated by a network of biochemical transformations and molecular signaling events that influence host physiology through local and systemic mechanisms. This review examines how probiotic microorganisms generate functional metabolites, including short-chain fatty acids, bile acid derivatives, and indole compounds, and how these molecules interact with host receptors and intracellular signaling pathways such as NF-κB, JAK/STAT, FXR, TGR5, AhR, and inflammasome-mediated signaling. In addition to metabolite-mediated signaling, probiotics may inhibit pathogens through organic acid production, bacteriocins, and quorum-quenching mechanisms, while also contributing to epithelial barrier integrity through modulation of tight-junction proteins and mucosal defenses. These interconnected pathways affect inflammation, metabolic regulation, host-microbe communication, and host defense against pathogens. The review further discusses pharmacomicrobiomic interactions, engineered probiotics, and emerging delivery technologies, highlighting the importance of strain specificity, host context, and microbiome composition in determining therapeutic outcomes. These findings underscore the importance of mechanistic frameworks for the rational development of targeted microbiome-based interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.